Open AccessImpact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009–2013
Author(s) -
Miwako Kobayashi,
Godfrey Bigogo,
Lindsay Kim,
Ondari D. Mogeni,
Laura Conklin,
Arthur Odoyo,
Herine Odiembo,
Fabiana Cristina Pimenta,
Dominic Ouma,
Aaron M. Harris,
Kennedy Odero,
Jennifer Milucky,
Alice Ouma,
George Aol,
Allan Audi,
Clayton Onyango,
Leonard Cosmas,
Geofrey Jagero,
Jennifer L. Farrar,
Maria da Glória Carvalho,
Cynthia G. Whitney,
Robert F. Breiman,
Fernanda C. Lessa
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz285
Subject(s) - medicine , carriage , pneumococcal conjugate vaccine , streptococcus pneumoniae , pneumococcal infections , pediatrics , antibiotics , human immunodeficiency virus (hiv) , immunology , virology , microbiology and biotechnology , biology , pathology
Kenya introduced 10-valent pneumococcal conjugate vaccine (PCV10) among children <1 year in 2011 with catch-up vaccination among children 1-4 years in some areas. We assessed changes in pneumococcal carriage and antibiotic susceptibility patterns in children <5 years and adults.